Effects of Canakinumab On The Progression of Type 1 Diabetes In New Onset Subjects.

Trial Profile

Effects of Canakinumab On The Progression of Type 1 Diabetes In New Onset Subjects.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Oct 2016

At a glance

  • Drugs Canakinumab (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms TrialNet
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 08 Apr 2013 Results published in the Lancet.
    • 05 Apr 2013 Primary endpoint 'C-peptide-levels' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top